Treating PKP2R413X/+ hiPSC-CMs with SB improved CX43 localization and restored Ca2+ wave velocities in PKP2R413X/+ tissues, changes that would be anticipated to reduce the myocardial substrate’s vulnerability to arrhythmia. This evidence concerns the gene GJA1 and Arrhythmia.